Women’s Health Initiative
The Catalytic Impact Foundation accelerates innovation in women’s health by supporting top teams developing technologies that address conditions that affect women exclusively, differently or disproportionately. We focus on transformational technologies that will change outcomes - dramatically improving quality of care, in a way that is accessible and scalable.
Many women’s health conditions are poorly understood, with
few available treatments.
Women’s Health Case Studies
-
AOA Diagnostics
Identifying ovarian cancer early in women with
non-specific symptoms through a highly accurate yet non-invasive liquid biopsy blood test. -
OCON Healthcare
Addressing a myriad of women’s health issues, including endometriosis and fibroids through drug-delivery via the uterus, while avoiding systemic side effects.
-
Raydiant Oximetry
Advancing non-invasive fetal pulse oximeter measuring fetal oxygen saturation to accurately predict fetal distress and prevent unnecessary Caesarean sections.
By contributing to the CIF Women’s Health Initiative,
you are supporting investments in emerging life science companies, advancing scientific progress towards treatments for diseases that disproportionately impact women.
"Women deserve a long-term solution to problems that have persisted too long in women's health and healthcare. The time has come for a permanent, evergreen, self-sustaining system to accelerate innovation in healthcare dedicated to women's health issues. The time to act is now.”
-Richard Lipkin, CIF Co-Founder
Women make up more than 50% of the population, but in venture capital investing women’s health is considered a “niche” area, and as a result is severely underfunded.”
-Rachel Butler, CIF President